Influenza A NP Antibody (AA5H) is a mouse monoclonal IgG2a antibody that detects Influenza A nucleoprotein (NP) by immunofluorescence (IF). Anti-Influenza A NP antibody (AA5H) recognizes the viral protein, which plays a crucial role in the viral life cycle by associating with the viral RNA genome, forming ribonucleoprotein complexes essential for replication and transcription. Influenza A NP (AA5H) monoclonal antibody targets the protein within the nucleus of infected cells, where NP facilitates the transport of viral RNA and proteins, ensuring efficient viral replication. NP presence in the nucleus is vital for the assembly of new viral particles, making NP a key target for therapeutic interventions and vaccine development. Anti-Influenza A NP antibody (AA5H) provides reliable detection, enabling researchers to study viral infection dynamics and cellular responses.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Influenza A NP Antibody (AA5H) References:
- Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. | Altstein, AD., et al. 2006. Arch Virol. 151: 921-31. PMID: 16292596
- Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. | Lo, CY., et al. 2008. Vaccine. 26: 2062-72. PMID: 18378366
- A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. | Kakisaka, M., et al. 2015. PLoS Pathog. 11: e1005062. PMID: 26222066
- Depressed Hypoxic and Hypercapnic Ventilatory Responses at Early Stage of Lethal Avian Influenza A Virus Infection in Mice. | Zhuang, J., et al. 2016. PLoS One. 11: e0147522. PMID: 26808681
- Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. | Liu, CL., et al. 2016. Sci Rep. 6: 21662. PMID: 26916998
- Intrinsically disordered region of influenza A NP regulates viral genome packaging via interactions with viral RNA and host PI(4,5)P2. | Kakisaka, M., et al. 2016. Virology. 496: 116-126. PMID: 27289560
- Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice. | Hinkula, J., et al. 2019. Vaccines (Basel). 7: PMID: 31315253
- Modeling the Influenza A NP-vRNA-Polymerase Complex in Atomic Detail. | Miner, JC., et al. 2021. Biomolecules. 11: PMID: 33477938
- Nanozymes featuring a mesoporous silica shell for rapid enrichment and ultrasensitive lateral flow immunoassay of influenza A. | Liang, J., et al. 2025. Anal Chim Acta. 1335: 343474. PMID: 39643324
- A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells. | Oukka, M., et al. 1994. J Immunol. 152: 4843-51. PMID: 8176207